Abstract
We reviewed the findings of adrenocortical scintigraphy with131I-6-beta-iodomethyl-19-norcholesterol (NCL-6-131I) of 39 patients to clarify its role in the evaluation of unilateral adrenal or juxtaadrenal masses incidentally discovered by CT, ultrasonography or plain radiography. Twenty-seven benign adrenal masses showed various scintigraphic findings (hot nodule: 12 silent adenomas, warm nodule: one solid mass, normal appearance: one cyst and 2 solid masses, diffuse decrease: each one; solid mass, myelolipoma, ganglioneuroma and calcified adrenal and partial or complete defect: each one; solid mass, myelolipoma and ganglioneuroma and 2 cysts and 2 pheochromocytomas); while a partial or complete defect was shown in a nonfunctioning carcinoma and 3 metastases and a complete defect or inhomogeneous uptake without opposite adrenal visualization was shown in 2 patients with cortisol-producing carcinoma. Therefore a hot nodule and an inhomogenous uptake or complete defect with nonvisualization of the opposite adrenal are specific to a benign tumor and a cortisol-producing carcinoma, respectively. The impaired tumor uptake of NCL-6-131I is a nonspecific finding. The scintigraphic findings of juxtaadrenal masses were normal in 4 and deviated adrenals in 2. Thus adrenocortical scintigraphy can identify silent adenomas and cortisol-producing carcinomas among the adrenal masses and may help to differentiate juxtaadrenal from adrenal masses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Geelhoed GW, Drug EM: Management of the adrenal “incidentaloma”.Surgery 92: 866–874, 1982
Prinz RA, Brooks MH, Churchill R, et al: Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?.JAMA: 701–704, 1982
Siekavizza JL, Bernardino ME, Samaan NA: Suprarenal masses and its differential diagnosis.Urology 181: 625–632, 1981
Glazer GM, Woolsey EJ, Borrello J, et al: Adrenal tissue characterization using MR imaging.Radiology 158: 73–79, 1986
Mitnick JS, Bosniak MA, Megibow AJ, et al: Non-functioning adrenal adenomas discovered incidentally on computed tomography.Radiology 148: 495–499, 1983
Reinig JW, Doppman JL, Dwyer AJ, et al: MRI of indeterminate adrenal masses.AJR 147: 493–496, 1986
Shirkhoda A: Current diagnostic approach to adrenal abnormalities.J Comput Tomogr 8: 277–285, 1984
Chezmar JL, Robbins SM, Nelson RC et al: Adrenal masses: Characterization with T1-weighted MR imaging.Radiology 166: 357–359, 1988
Hussain S, Belldegrun A, Seltzer SE, et al: Differentiation of malignant from benign adrenal masses: Predictive indices on computed tomography.AJR 144: 61–65, 1985
Oliver TW, Bernardino ME, Miller JI, et al: Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma.Radiology 153: 217–218, 1984
Kojima M, Maeda M, Ogawa H, et al: New adrenal scanning agent. JNucl Med 16: 666–668, 1975
Sarkar SD, Beierwaltes WH, Basmadjian GP, et al: A new and superior adrenal scanning agent, NP-59.J Nucl Med 16: 1038–1042, 1975
Kazerrooni EA, Sisson JC, Gross MD, et al: Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol(NP-59) imaging.J Nucl Med 31: 526–534, 1990
Nakajo M: Adrenal imaging with131I-Adosterol (NCL-6-131I) by diverging and pinhole methods. II. Analysis of abnormal adrenal images.Nipp Act Radiol 42: 160–187, 1982
Francis IR, Smid A, Gross MD, et al: Adrenal masses in oncologic patients: Functional and morphologic evaluation.Radiology 166: 353–356, 1988
Gross MD, Wilton GP, Shapiro B, et al: Functional and scintigraphic evaluation of the silent adrenal mass.J Nucl Med 28: 1401–1407, 1987
Rizza RA, Wahner HW, Spelsberg TC, et al: Visualization of nonfunctioning adrenal adenomas with iodocholesterol: Possible relationship to subcellular distribution of tracer.J Nucl Med 19: 458–463, 1978
Nakajo M: Adrenal imaging with131I-Adosterol (NCL-6-131I) by diverging and pinhole methods. I. Analysis of normal adrenal images.Nipp Act Radiol 41: 985–997, 1981
Hasegawa Y, Nakano S, Ibuka K, et al: Concentration of99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas.Eur J Nucl Med 10: 255–258, 1985
Nakajo M, Sakata H, Shirono K, et al: Application of ACTH stimulation to adrenal imaging with radio-iodochohsterol.Clin Nucl Med 8: 112–120, 1983
Gross MD, Shapiro B, Bouffard A, et al: Distinguishing benign from malignant euadrenal masses.Ann Intern Med 109: 613–618, 1988
Charbonnel B, Chatal JF, Ozanne P: Does the corticoadrenal adenoma with “pre-Cushing’s syndrome” exist?.J Nucl Med 22: 1059–1161, 1981
Copeland PM: The incidentally discovered adrenal mass.Ann Intern Med 98: 940–945, 1983.
Grazer HS, Weyman PJ, Sagel SS, et al: Nonfunctioning adrenal masses: Incidental discovery on computed tomography.AJR 139: 81–85, 1982
Guerrero LA: Diagnostic and therapeutic approach to incidental adrenal mass.Urology 26: 435–440, 1985
Nakajo M, Shapiro B, Copp J, et al: The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine(I-131 MIBG) in man: Evaluation by scintigraphy.J Nucl Med 24: 672–682, 1983
Shapiro B, Copp JE, Sisson JC, et al: Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: Experience in 400 cases.J Nucl Med 26: 576–585, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakajo, M., Nakabeppu, Y., Yonekura, R. et al. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses. Ann Nucl Med 7, 157–166 (1993). https://doi.org/10.1007/BF03164960
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164960